Antihypertensive Agents (Medicinal Chemistry)

0.0(0)
studied byStudied by 0 people
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/59

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

60 Terms

1
New cards

thiazides

warning for sulfonamide hypersensitivity reactions (nausea, allergy, hematopoietic disease

2
New cards

benzothiadizine

Thiazides derived from ___________ which are bicyclic heterocyclic benzenes.

3
New cards

lipophilicity and duration of action

What do the alkyl groups on position 2 on thiazides increase?

4
New cards

increase potency

What does the lipophilic groups on the position 3 of the thiazides do?

5
New cards

increases activity 10 fold

What does the lipophilic groups on the position 3-4 of the thiazides do?

6
New cards

chlorine

What is the electron withdrawing group on the position 6 of thiazides?

7
New cards

sulfonamide

The _________ on position 7 adds activity (hyper-sensitivity) to thiazides.

8
New cards

Chlorothiazide

-Representative thiazide diuretic.

-It was patented in 1956 and approved for medical use in 1958.

-Warning: sulfonamide sensitivity!

9
New cards

Hydrochlorothiazide

-Widely used thiazide diuretic.

-Prototypical thiazide.• 3-4 bond saturated => more active than chlorothiazide.

-Called HCTZ.

-Warning: sulfonamide sensitivity!

10
New cards

phthalimide ring

Chlorthalidone has a structural modification which is the __________

<p>Chlorthalidone has a structural modification which is the __________</p>
11
New cards

Indapamide

-Structure: 1-(4-chloro-3-sulfamoylbenzamido)-2-methylindoline.

-Displays a chlorobenzenesulfonamide.

-No benzothiadiazine scaffold.

-Longer activity and inhibits carbonic anhydrase.

-Warning: sulfonamide sensitivity!

<p>-Structure: 1-(4-chloro-3-sulfamoylbenzamido)-2-methylindoline.</p><p>-Displays a chlorobenzenesulfonamide.</p><p>-No benzothiadiazine scaffold.</p><p>-Longer activity and inhibits carbonic anhydrase.</p><p>-Warning: sulfonamide sensitivity!</p>
12
New cards

"sulfa" allergy

-3-6% of the population

-sulfonilamide (sulfone + amide)

13
New cards

sulfonamide

is a synthetic derivative of p-aminobenzenesulfonamide,which is sulfonilamide in antibiotics like sulfamethoxazole (SMX)

14
New cards

potassium-sparing diuretics

-Reduce urinary excretion of K+.

-May cause hyperkalemia at different levels.

-Combination with the other diuretics to maintain the [K+] balance.

-May not have a clinically significant effect on BP

15
New cards

Spironolactone

-Cyclized (lactone) aldosterone (steroid hormone) derivative

-Competitive antagonist against aldosterone

-Selective aldosterone receptor blocker

-Old and widely used drug

16
New cards

Eplerenone

-Cyclized aldosterone (steroid hormone) derivative

-Structurally similar to Spironolactone (small chemical modifications)

-Competitive antagonist against aldosterone

-Selective aldosterone receptor blocker

-Widely used potassium-sparing diuretic

17
New cards

triamterene

-Sodium channel blocker

-Three highly aminated aromatic rings

-Bicyclic ring (pyrimidine and pyrazine)

-Weak potency

18
New cards

Amiloride

-Sodium channel blocker

-Open-ring analog of triamterene (chlorination instead of phenyl)

-100-fold more potent than triamterene

19
New cards

propranolol

s a racemic mixture of 2 enantiomers where the S(-)-enantiomer has approximately 100 times the binding affinity for beta adrenergic receptors

20
New cards

Metoprolol

-Selective blocker of the β1-adrenergic receptors in the heart.

-Chemically similar to propranolol, but with a hydroxyethyl group attached to the C4 carbon of a phenol group instead of a naphthalene(1-naphthol)

21
New cards

Verapamil

As a phenylbutylamine, this compound

contains a phenylbutylamine moiety,

which consists of a phenyl group

substituted at the fourth carbon by a

butan-1-amine

22
New cards

Dilitiazem

As a benzothiazepine, it contains a benzene fused to a thiazepine ring (a seven-membered ring with a nitrogen atom and a sulfur atom replacing two carbon atoms)

23
New cards

Nifedipine

As a dihydropyridinecarboxylic acid, it contains a

dihydropyridine moiety bearing

carboxylic acid groups

24
New cards

ACEis

Inhibit, directly or indirectly, the converting enzyme peptidyl dipeptidase that hydrolyzes angiotensin I to angiotensin II,

consequently decreasing inactivation of bradykinin (a potent

vasodilator)

25
New cards

Captopril

-Competitive inhibitor of ACE.

-Sulfhydryl-containing analog of proline.

-Sulfhydryl moiety enables ACE inhibition

26
New cards

Enalapril

-Prodrug which is converted by hydrolysisof the ethyl ester to enalaprilat, the activeACE inhibitor form with carboxylic acid.

- (S)-(-)-1-[N-(1-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl]-L-proline. Modifieddipeptide containing Ala and Pro

27
New cards

prodrug

Enalapril

28
New cards

active form

Enalaprilat

29
New cards

Perindopril

-ACE inhibitor

-As a prodrug, its ester group is cleaved in the liver and converted into its carboxylic acidactive form Perindoprilat

-Non-sulfhydryl proline-containing dipeptide

30
New cards

prodrug

Perindopril

31
New cards

active form

Perindoprilat

32
New cards

Ramipril

-ACE inhibitor.

-As a prodrug, its ester group is cleaved in the liver, and to a lesser extent in the kidneys,

and converted into its carboxylic acid active form Ramiprilat.

-Non-sulfhydryl proline-containing dipeptide

33
New cards

prodrug

Ramipril

34
New cards

active form

Ramiprilat

35
New cards

Trandolapril

-ACE inhibitor.

-As a prodrug, its ester group is modified in the liver, to its biomedically active its carboxylic

acid active form, Trandolaprilat.

-Non-sulfhydryl Proline-containing dipeptide

36
New cards

prodrug

Trandolapril

37
New cards

active form

Trandolaprilat

38
New cards

Fosinopril

-ACE inhibitor.

-Phospho ester-containing prodrug that is rapidly

hydrolyzed in the gastrointestinal mucosa and liver to

Fosinoprilat (phosphonic acid active form).

-Analog of proline

39
New cards

prodrug

Fosinopril

40
New cards

active form

fosinoprilat

41
New cards

benazepril

-ACE inhibitor.

-As a prodrug, its ester group is cleaved in the

liver and converted into its carboxylic acid

active form Benazeprilat.

-Non-sulfhydryl and benzazepine

42
New cards

prodrug

benazepril hydrochloride

43
New cards

active form

benaeprilat

44
New cards

quinapril

-ACE inhibitor.

-As a prodrug, its ester group is cleaved in the liver and converted into its carboxylic acid

active form Quinaprilat.

-Non-sulfhydryl and quinolone

45
New cards

prodrug

quinapril

46
New cards

active form

quinaprilat

47
New cards

moexipril

-ACE inhibitor.

-Ester-containing prodrug that is rapidly hydrolyzed in the gastrointestinal mucosa and liver

to Moexiprilat (carboxylic acid active form).

-Non-sulfhydryl and di-O-methyl quinolone

48
New cards

prodrug

Moexipril

49
New cards

active form

Moexiprilat

50
New cards

sulfhydryl

can cause taste disturbances and maybe skin rashes

51
New cards

captopril

is preferable in patients with underlying liver issues

52
New cards

Dicarboxylic

_______ ACEis are more potent than captopril

53
New cards

no

Does captopril have activation?

54
New cards

benzazepine

What is the scaffold of benazepril?

55
New cards

quinolone

What is the scaffold of quinapril?

56
New cards

methylated quinolone

What is the scaffold of moexipril?

57
New cards

sulfhydryl + carboxylic

What are the functional groups of captopril?

58
New cards

phosphonic + carboxylic

What are the functional groups of fosinopril?

59
New cards

ARBs

-sartan

-Bind and block angiotensin II receptor

-similar benefits of ACEis, but with no action on bradykinin metabolism and are more selective blockers of angiotensin effects that ACEis

60
New cards

losartan

-As a biphenyl, this organic compound contains benzene rings linked together by a C-C bond.

-was granted FDA approval on 14 April 1995

-First marketed blocker of angiotensin II type 1 (AT1)